Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients.


Journal

The Laryngoscope
ISSN: 1531-4995
Titre abrégé: Laryngoscope
Pays: United States
ID NLM: 8607378

Informations de publication

Date de publication:
10 2021
Historique:
revised: 15 06 2021
received: 03 05 2021
accepted: 12 07 2021
pubmed: 22 7 2021
medline: 21 9 2021
entrez: 21 7 2021
Statut: ppublish

Résumé

The aim of this study was to evaluate the correlations between the severity and duration of olfactory dysfunctions (OD), assessed with psychophysical tests, and the viral load on the rhino-pharyngeal swab determined with a direct method, in patients affected by coronavirus disease 2019 (COVID-19). Prospective cohort study. Patients underwent psychophysical olfactory assessment with Connecticut Chemosensory Clinical Research Center test and determination of the normalized viral load on nasopharyngeal swab within 10 days of the clinical onset of COVID-19. Sixty COVID-19 patients were included in this study. On psychophysical testing, 12 patients (20% of the cohort) presented with anosmia, 11 (18.3%) severe hyposmia, 13 (18.3%) moderate hyposmia, and 10 (16.7%) mild hyposmia with an overall prevalence of OD of 76.7%. The overall median olfactory score was 50 (interquartile range [IQR] 30-72.5) with no significant differences between clinical severity subgroups. The median normalized viral load detected in the series was 2.56E+06 viral copies/10 The presence of OD does not seem to be useful in identifying subjects at risk for being super-spreaders or who is at risk of developing long-term OD. Similarly, the pathogenesis of OD is probably related to individual factors rather than to viral load and activity. 4 Laryngoscope, 131:2312-2318, 2021.

Identifiants

pubmed: 34287905
doi: 10.1002/lary.29777
pmc: PMC8441733
doi:

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2312-2318

Informations de copyright

© 2021 The Authors. The Laryngoscope published by Wiley Periodicals LLC on behalf of The American Laryngological, Rhinological and Otological Society, Inc.

Références

J Laryngol Otol. 2020 Dec;134(12):1123-1127
pubmed: 33190655
JAMA. 2020 May 26;323(20):2089-2090
pubmed: 32320008
Rhinology. 2021 Feb 1;59(1):26-31
pubmed: 33320115
Chem Senses. 2020 Oct 9;45(7):609-622
pubmed: 32564071
Front Med (Lausanne). 2020 Dec 02;7:589409
pubmed: 33344476
J Laryngol Otol. 2020 Aug;134(8):703-709
pubmed: 32782030
Lancet Infect Dis. 2020 Jun;20(6):697-706
pubmed: 32224310
Sci Adv. 2020 Jul 31;6(31):
pubmed: 32937591
Neuron. 2020 Jul 22;107(2):219-233
pubmed: 32640192
Infect Dis Ther. 2020 Sep;9(3):573-586
pubmed: 32725536
Head Neck. 2020 Jun;42(6):1252-1258
pubmed: 32342566
JAMA Neurol. 2020 Aug 1;77(8):1028-1029
pubmed: 32469400
J Virol. 2008 Aug;82(15):7264-75
pubmed: 18495771
Chem Senses. 2020 Jun 17;:
pubmed: 32556089
Elife. 2021 Feb 23;10:
pubmed: 33620317
Int Forum Allergy Rhinol. 2020 Aug;10(8):944-950
pubmed: 32301284
Eur Arch Otorhinolaryngol. 2021 May 13;:
pubmed: 33983525
Lancet. 2020 Jul 18;396(10245):166
pubmed: 32659210
J Laryngol Otol. 2020 Jul;134(7):571-576
pubmed: 32605666
Front Med (Lausanne). 2020 Nov 24;7:582802
pubmed: 33330539
Acad Radiol. 2020 Aug;27(8):1191
pubmed: 32425479
Rhinology. 2021 Feb 1;59(1):21-25
pubmed: 33290446
J Infect. 2021 Mar;82(3):414-451
pubmed: 33131699
Head Neck. 2020 Jul;42(7):1570-1576
pubmed: 32357379
Int Forum Allergy Rhinol. 2020 Sep;10(9):1103-1104
pubmed: 32342636
Laryngoscope. 2020 Jul;130(7):1787
pubmed: 32237238
J Infect Dis. 2021 May 20;223(9):1528-1537
pubmed: 33585934
Crit Care. 2020 Apr 23;24(1):170
pubmed: 32326952
J Laryngol Otol. 2021 May;135(5):436-441
pubmed: 33888166
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
Pathogens. 2020 Jul 31;9(8):
pubmed: 32752123
ACS Chem Neurosci. 2020 Jun 3;11(11):1520-1522
pubmed: 32427468
Laryngoscope. 2020 Nov;130(11):2680-2685
pubmed: 32794209
Head Neck. 2020 Jul;42(7):1560-1569
pubmed: 32437022
Laryngoscope. 2021 May;131(5):1095-1100
pubmed: 33404079
Am J Otolaryngol. 2021 May-Jun;42(3):102911
pubmed: 33476975
Pathogens. 2021 Jan 12;10(1):
pubmed: 33445604
Chem Senses. 2021 Jan 1;46:
pubmed: 33575808
J Infect. 2020 Sep;81(3):357-371
pubmed: 32615199
J Infect. 2020 Apr;80(4):401-406
pubmed: 32112886
Otolaryngol Head Neck Surg. 2020 Jul;163(1):114-120
pubmed: 32423357
J Clin Microbiol. 2020 Oct 21;58(11):
pubmed: 32817231
J Otolaryngol Head Neck Surg. 2020 Aug 6;49(1):56
pubmed: 32762737
Laryngoscope. 2020 Nov;130(11):2526-2531
pubmed: 32678494
Otolaryngol Head Neck Surg. 2020 Jul;163(1):12-15
pubmed: 32366160
Chem Senses. 2020 Dec 5;45(9):865-874
pubmed: 33245136
Acta Otolaryngol. 2021 Jun;141(6):615-620
pubmed: 33733988
Infection. 2021 Feb;49(1):117-126
pubmed: 33231841
Int Forum Allergy Rhinol. 2020 Jul;10(7):821-831
pubmed: 32329222
Head Neck Pathol. 2021 Mar;15(1):225-235
pubmed: 32816230
Clin Infect Dis. 2021 May 18;72(10):e685-e686
pubmed: 32785682
Eur Arch Otorhinolaryngol. 2021 Aug;278(8):2851-2859
pubmed: 33452919
J Clin Microbiol. 2016 Apr;54(4):928-33
pubmed: 26763967

Auteurs

Luigi Angelo Vaira (LA)

Maxillofacial Surgery Operative Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.
Biomedical Science PhD School, Biomedical Science Department, University of Sassari, Sassari, Italy.

Giovanna Deiana (G)

Biomedical Science PhD School, Biomedical Science Department, University of Sassari, Sassari, Italy.
Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Jerome R Lechien (JR)

COVID-19 Task Force of the Young-Otolaryngologists of the International Federation of Oto-rhino-laryngological Societies (YO-IFOS), Paris, France.
Department of Human and Experimental Oncology, Faculty of Medicine UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.

Andrea De Vito (A)

Infectious and Tropical Diseases Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Andrea Cossu (A)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Marco Dettori (M)

Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Arcadia Del Rio (A)

Biomedical Science PhD School, Biomedical Science Department, University of Sassari, Sassari, Italy.
Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Sven Saussez (S)

COVID-19 Task Force of the Young-Otolaryngologists of the International Federation of Oto-rhino-laryngological Societies (YO-IFOS), Paris, France.
Department of Human and Experimental Oncology, Faculty of Medicine UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), Mons, Belgium.

Giordano Madeddu (G)

Infectious and Tropical Diseases Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Sergio Babudieri (S)

Infectious and Tropical Diseases Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Alessandro G Fois (AG)

Respiratory Diseases Operative Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Clementina Cocuzza (C)

Medicine and Surgery Department, Bicocca University of Milan, Milan, Italy.

Claire Hopkins (C)

King's College, London, United Kingdom.

Giacomo De Riu (G)

Maxillofacial Surgery Operative Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Andrea Fausto Piana (AF)

Biomedical Science PhD School, Biomedical Science Department, University of Sassari, Sassari, Italy.
Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH